Cargando…
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects http://ow.ly/Gaq530o9kEg
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://www.ncbi.nlm.nih.gov/pubmed/31191729 http://dx.doi.org/10.1183/20734735.0016-2019 |
_version_ | 1783423303019397120 |
---|---|
author | Suarez-Cuartin, Guillermo Molina-Molina, Maria |
author_facet | Suarez-Cuartin, Guillermo Molina-Molina, Maria |
author_sort | Suarez-Cuartin, Guillermo |
collection | PubMed |
description | The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects
http://ow.ly/Gaq530o9kEg |
format | Online Article Text |
id | pubmed-6544796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-65447962019-06-12 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Suarez-Cuartin, Guillermo Molina-Molina, Maria Breathe (Sheff) Expert Opinion The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects
http://ow.ly/Gaq530o9kEg European Respiratory Society 2019-06 /pmc/articles/PMC6544796/ /pubmed/31191729 http://dx.doi.org/10.1183/20734735.0016-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Expert Opinion Suarez-Cuartin, Guillermo Molina-Molina, Maria Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title | Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title_full | Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title_fullStr | Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title_full_unstemmed | Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title_short | Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study |
title_sort | assessing quality of life of idiopathic pulmonary fibrosis patients: the instage study |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://www.ncbi.nlm.nih.gov/pubmed/31191729 http://dx.doi.org/10.1183/20734735.0016-2019 |
work_keys_str_mv | AT suarezcuartinguillermo assessingqualityoflifeofidiopathicpulmonaryfibrosispatientstheinstagestudy AT molinamolinamaria assessingqualityoflifeofidiopathicpulmonaryfibrosispatientstheinstagestudy |